Feasibility and Response of Concurrent Weekly Docetaxel with Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Objective: (1) To study the feasibility, adverse effects and response of concurrent weekly Docetaxel with radical radiotherapy in inoperable locally advanced head and neck squamous cell carcinoma. (2) To assess the compliance and tolerance of weekly Docetaxel with radiotherapy. Material and Met...
Main Authors: | Jomon Raphael C, Rajesh I, Rajesh B, Selvamani B, Subhashini John |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2015-03-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/5614/10819_CE(Ra1)_F(GH)_PF1(PAK)_PFA(AK)_PF2(PAG).pdf |
Similar Items
-
3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
by: Seth Helfenstein, et al.
Published: (2019-02-01) -
Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
by: Moon Jin Kim, et al.
Published: (2019-09-01) -
Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma
by: Yusuke Uchinami, et al.
Published: (2023-12-01) -
Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
by: Muhammad Shahid Iqbal, et al.
Published: (2017-04-01) -
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once‐a‐week versus once‐every‐3‐weeks cisplatin
by: Nandini S. Menon, et al.
Published: (2022-11-01)